Drugs / TGN-S11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05826275 | Jun 2023 → May 2025 | virus associated tumor | Toragen, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TGN-S11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05826275 ↗ |
| Modality | Small molecule | “Small Molecule” NCT05826275 ↗ |